SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Jul 16, 2019
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: July 16, 2019 · CIK: 0001585608 · Accession: 0001104659-19-040553
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-231399
Letter
Re: Jaguar Health, Inc.
July 16, 2019
Via EDGAR
Jeffrey Gabor U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-231399
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission on Thursday, July 18, 2019, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant hereby authorizes each of Donald C. Reinke, Esq. and Michael S. Lee, Esq. of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration.
Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358.
Very truly yours,
Jaguar Health, Inc.
Show Raw Text
CORRESP 1 filename1.htm July 16, 2019 Via EDGAR Jeffrey Gabor U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Jaguar Health, Inc. Registration Statement on Form S-1 File No. 333-231399 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission on Thursday, July 18, 2019, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant hereby authorizes each of Donald C. Reinke, Esq. and Michael S. Lee, Esq. of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration. Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358. Very truly yours, Jaguar Health, Inc. /s/ Lisa A. Conte Lisa A. Conte Chief Executive Officer and President Jaguar Health, Inc. · 201 Mission Street, Suite 2375 · San Francisco, CA 94105 Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311 · https://jaguar.health